Clinical Trial Update: Dose Assessment of Melatonin in Sepsis Trial [Phase 1, Phase 2]

View source ↗

Summary

A dose-assessment trial of melatonin for sepsis (Phase 1/Phase 2) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: University of Aberdeen | Conditions: Sepsis | Phase 1, Phase 2 | Status: WITHDRAWN